| scholarly article | Q13442814 |
| P356 | DOI | 10.4103/0971-5916.162116 |
| P8608 | Fatcat ID | release_vehqrfff45bzdnv4dxodcgidtu |
| P932 | PMC publication ID | 4557252 |
| P698 | PubMed publication ID | 26261168 |
| P50 | author | Vivekanand Jha | Q38800410 |
| P2093 | author name string | Vinod Kumar | |
| Anil Bhansali | |||
| Bikash Medhi | |||
| Uma Nahar Saikia | |||
| Pinaki Dutta | |||
| Shobhit Bhansali | |||
| P2860 | cites work | Mesenchymal stem cells avoid allogeneic rejection | Q21245658 |
| Diabetes Treatment — Bridging the Divide | Q22250871 | ||
| Stem cell therapy in a caprine model of osteoarthritis | Q28191365 | ||
| Current status of islet cell replacement and regeneration therapy | Q33738705 | ||
| Insulin-producing cells from human adipose tissue-derived mesenchymal stem cells detected by atomic force microscope | Q34186756 | ||
| Electrofusion of mesenchymal stem cells and islet cells for diabetes therapy: a rat model | Q34749610 | ||
| Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell mass | Q35055522 | ||
| Mesenchymal stem cells for the treatment of diabetes | Q35976665 | ||
| Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity | Q35976735 | ||
| Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. | Q40001030 | ||
| Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | Q40321403 | ||
| Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function | Q41020720 | ||
| Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus | Q43290819 | ||
| Bone marrow-derived stem cells initiate pancreatic regeneration. | Q44486484 | ||
| Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. | Q44538164 | ||
| Reversal of experimental diabetes by multiple bone marrow transplantation | Q45238329 | ||
| Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets | Q45882154 | ||
| Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice | Q46638995 | ||
| Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury | Q47578118 | ||
| Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. | Q51894736 | ||
| Position Statement of the Chinese Diabetes Society regarding stem cell therapy for diabetes. | Q53209262 | ||
| International trial of the Edmonton protocol for islet transplantation. | Q54032399 | ||
| Recruitment of Bone Marrow-Derived Endothelial Cells to Sites of Pancreatic -Cell Injury | Q57720869 | ||
| Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice | Q83672252 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 63-71 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Indian Journal of Medical Research | Q6020786 |
| P1476 | title | Effect of mesenchymal stem cells transplantation on glycaemic profile & their localization in streptozotocin induced diabetic Wistar rats | |
| P478 | volume | 142 |
| Q94410005 | Authors' response |
| Q40967128 | Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity |
| Q90317106 | Effect of Stem Cells and Gene Transfected Stem Cells Therapy on the Pancreas of Experimentally Induced Type 1 Diabetes |
| Q89958204 | Effect of Stem Cells, Ascorbic Acid and SERCA1a Gene Transfected Stem Cells in Experimentally Induced Type I Diabetic Myopathy |
| Q47229723 | Evaluating KIND1 human embryonic stem cell-derived pancreatic progenitors to ameliorate streptozotocin-induced diabetes in mice. |
| Q37460214 | Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes |
| Q42915227 | Is the improved function of streptozotocin treated pancreas truly due to transdifferentiation/fusion of transplanted MSCs? |
| Q33691629 | Mesenchymal stem cell therapy in type 2 diabetes mellitus |
| Q90049988 | Therapeutic Effects of Adipose Stem Cells from Diabetic Mice for the Treatment of Type 2 Diabetes |
| Q51823569 | Transplantation of stromal-derived factor 1α and basic fibroblast growth factor primed insulin-producing cells reverses hyperglycaemia in diabetic rats. |
Search more.